Navigation Links
How Early Can We Detect Cardiovascular Disease Less Expensively... Even in Childhood? 'PAT' is the Invisible Signal

Itamar Medical

American Heart Association's Scientific Sessions 2007

Press Breakfast

ORLANDO, Fla., Nov. 1 /PRNewswire-USNewswire/ -- The following is being issued by Itamar Medical:

WHO: Dr. Amir Lerman, Professor of Medicine, Mayo Clinic,

Rochester, MN

Dr. Peter Friberg, Sahlgrenska University Hospital,

Goteborg, Sweden

Mr. Israel Schreiber, President and CEO, Itamar Medical

Dr. Mark Pritzker, Cardiologist, University of Minnesota

Medical Center

Dr. Giora Yaron - Co-Chairman, Itamar Board of Directors.

WHAT: Itamar Medical AHA Press Breakfast -

Endothelial dysfunction - the underappreciated cardiovascular

risk factor

WHEN: Monday, November 5, 2007 8:00 a.m.

WHERE: The Aviary Room

Celebration Hotel

700 Bloom St.

Celebration, FL.

WHY: Find out why PAT Technology is the "buzz" at AHA

It's been nearly a decade since the Nobel Prize was awarded

for discovering the link between endothelial dysfunction and

cardiovascular disease. The key is recognizing subtle changes

in blood flow, called peripheral arterial tone (PAT).

Research released at this AHA conference validates this basic


-- Framingham Heart Study uses PAT Technology to find links

between endothelial dysfunction and cardiovascular risk


-- Swedish scientists note that anger, depression and anxiety

in children are connected to measurable endothelial

changes that precedes heart disease

-- An international team of scientists discovers that

endothelial damage is widespread in malaria, suggesting

new avenues for treatment

-- Endothelial damage is common in insulin resistant

patients; treating insulin resistance could change the

outcome for many

-- Certain pacemakers implanted to boost the right side of

the heart are linked to endothelial damage and decreased

heart function.

About Itamar Medical

Itamar Medical Ltd., established in 1997, is a public (TASE: ITMR) medical technology company that developed the proprietary PAT(TM) (Peripheral Arterial Tone) signal. The PAT signal is a non-invasive "window" to the cardiovascular system and the autonomic nervous system.

PLEASE RSVP by November 2 to: Yvette Watson; (202) 944-1969.

SOURCE Itamar Medical
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gene linked to early puberty in girls
2. Cancer drugs in development nearly doubled since 1995
3. Nearly all asthma deaths preventable
4. Ductal lavage may detect early breast cancer
5. Doctors advice early anemia tests
6. Heart disease threat starts early in life for Diabetics
7. Early detection of prostate cancer
8. Early detection of heart attack
9. Early puberty linked to nutrition
10. Exercise to Prevent Early Breast Cancer
11. Drug Found To Bring Relief For Individuals With Early Parkinson’
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: